People are starting to hear about this and realising the exponential potential it has. A 50M market cap won’t be seen again with the potential to be the “go-to” ED treatment, good cash in the bank and spending under control (no costly EPO in future quarters )- in my opinion LTP will be the market share leader in the game within a few years … of which is a 3-5 billion dollar industry.
There is promise of another nasal delivery spray (not sure for what), potential partnerships and licensing … I am hanging around this stock for a while … there will be some bumps and profit taking (mad if you don’t) but the fundamentals of this company excite me … hahahaha
In search of growth: Pharma deals target precommercial biotech assets, page-13
Add LTP (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.65 |
Change
0.020(1.23%) |
Mkt cap ! $137.7M | |||
| Open | High | Low | Value | Volume |
| $1.65 | $1.65 | $1.62 | $79.99K | 48.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 2150 | $1.64 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.65 | 1577 | 3 |
View Market Depth
| Last trade - 10.05am 21/10/2024 (20 minute delay) ? |
| LTP (ASX) Chart |